hesperidin has been researched along with Hyperlipemia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Akhtar, F; Kumar, R; Rizvi, SI | 2 |
| Banerjee, S; Biswas, S; Chanda, J; Kar, A; Mukherjee, PK; Tiwari, A; Ulrich-Merzenich, G | 1 |
| Akash, MSH; Arafa, EA; Buabeid, MA; Chohan, TA; Jabeen, K; Munawar, SM; Rehman, K; Tariq, M | 1 |
| Pu, P | 1 |
| Chen, K; Chen, Y; Hu, Y; Jia, S; Li, X; Sun, C; Zhang, W; Zhao, X | 1 |
| Chaen, H; Kibata, M; Mishima, Y; Mitsuzumi, H; Miwa, Y; Sunayama, T; Tsuzaki, Y; Yamada, M | 1 |
7 other study(ies) available for hesperidin and Hyperlipemia
| Article | Year |
|---|---|
Protective effect of hesperidin in Poloxamer-407 induced hyperlipidemic experimental rats.
Topics: Animals; Disease Models, Animal; Hesperidin; Hyperlipidemias; Oxidative Stress; Poloxamer; Protective Agents; Protective Factors; Rats | 2021 |
Combining LC-MS/MS profiles with network pharmacology to predict molecular mechanisms of the hyperlipidemic activity of Lagenaria siceraria stand.
Topics: Animals; Atorvastatin; Chromatography, Liquid; Cucurbita; Flavonoids; Glycosides; Hesperidin; Hyperlipidemias; Hypertension; Insulins; Network Pharmacology; Obesity; Plant Extracts; Proto-Oncogene Proteins c-akt; Rats; Tandem Mass Spectrometry | 2023 |
Hesperidin attenuates altered redox homeostasis in an experimental hyperlipidaemic model of rat.
Topics: Animals; Biomarkers; Disease Models, Animal; Hesperidin; Homeostasis; Hyperlipidemias; Male; Oxidation-Reduction; Rats; Rats, Wistar | 2020 |
Hesperidin improves insulin resistance via down-regulation of inflammatory responses: Biochemical analysis and in silico validation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Obesity Agents; Diet, High-Fat; Disease Models, Animal; Drug Therapy, Combination; Hesperidin; Hyperlipidemias; Inflammation; Insulin Resistance; Leptin; Molecular Docking Simulation; Molecular Dynamics Simulation; Obesity; Orlistat; Rats, Wistar | 2020 |
[Protection mechanisms of hesperidin on mouse with insulin resistance].
Topics: Animals; Blood Glucose; Diet, High-Fat; Hesperidin; Hyperglycemia; Hyperlipidemias; Insulin; Insulin Resistance; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Obesity; Signal Transduction | 2016 |
Hypoglycemic and hypolipidemic effects of neohesperidin derived from Citrus aurantium L. in diabetic KK-A(y) mice.
Topics: Adipose Tissue, White; Adiposity; Animals; Blood Proteins; Citrus; Diabetes Mellitus, Type 2; Diet, Diabetic; Dietary Supplements; Gene Expression Regulation, Enzymologic; Glycated Serum Proteins; Glycoproteins; Hesperidin; Hyperglycemia; Hyperlipidemias; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Lipid Metabolism; Liver; Male; Mice, Inbred C57BL; Mice, Mutant Strains; Random Allocation; Specific Pathogen-Free Organisms | 2015 |
Effects of glucosyl hesperidin on serum lipids in hyperlipidemic subjects: preferential reduction in elevated serum triglyceride level.
Topics: Adult; Apolipoprotein C-II; Apolipoproteins B; Apolipoproteins C; Apolipoproteins E; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Glucosides; Hesperidin; Humans; Hyperlipidemias; Lipids; Male; Middle Aged; Particle Size; Triglycerides | 2004 |